It has been a full nine months since I started my fourth type of chemotherapy drug. My last bone marrow biopsy was in December of last year and revealed nearly 50% of the marrow was leukemia ridden, which is not a good long-term prognosis, thus leading my team of oncologists wanted to see how much leukemia was remaining in my blood and bone marrow with this recently approved new treatment


